María Luque graduated in Biochemistry in the mention of molecular and applied biochemistry from the University of the Seville in 2018. In 2019, she got her Master in medicines research, development, control and innovation from the University of Granada, where she developed her final master project in the determination of the anticarcinogenic and antioxidant effect of a compound on lymphoma. Currently, she works as an Early Stage Reseracher in the Precision Medicine and Metabolism lab at CIC bioGUNE and she is member of Atlas Molecular Pharma